Abstract
The use of light to control the expression of genes and the activity of proteins is a rapidly expanding field. Whereas many of these approaches use fusion between a light-activable protein and the protein of interest to control the activity of the latter, it is also possible to control the activity of a protein by uncaging a specific ligand. In that context, controlling the activation of a protein fused to the modified estrogen receptor (ERT) by uncaging its ligand cyclofen-OH has emerged as a generic and versatile method to control the activation of proteins quantitatively, quickly, and locally in a live organism. We present that approach and its uses in a variety of physiological contexts.
| Original language | English |
|---|---|
| Pages (from-to) | 1232-1238 |
| Number of pages | 7 |
| Journal | ChemBioChem |
| Volume | 19 |
| Issue number | 12 |
| DOIs | |
| State | Published - 18 Jun 2018 |
| Externally published | Yes |
Keywords
- caged compounds
- cyclofen-OH
- gene expression
- optogenetics
- photolysis
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Biochemistry
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Control of Protein Activity and Gene Expression by Cyclofen-OH Uncaging'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver